Text Size
40 studies found for:    " February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
22 Completed
Has Results 		Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
23 Recruiting Kaletra in Combination With Antiretroviral Agents
Condition: Human Immunodeficiency Virus
Interventions: Drug: lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Maraviroc;   Drug: Rilpivirine;   Drug: Etravirine
24 Completed
Has Results 		Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
25 Completed
Has Results 		Kaletra: Therapy With Double Protease Inhibitors
Condition: Human Immunodeficiency Virus
Intervention:
26 Completed
Has Results 		Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Condition: Human Immunodeficiency Virus-Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
27 Completed Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
Condition: HIV Infection
Intervention: Biological: blood test at day one
28 Recruiting Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Condition: HIV Infection
Interventions: Biological: AGS-004;   Biological: Placebo
29 Recruiting Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
30 Completed Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
Condition: HIV Infection
Intervention:
31 Completed
Has Results 		Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
Condition: HIV-1 Infections
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
32 Enrolling by invitation Surveillance of Kaletra in Korean Patients
Condition: HIV-1 Infection
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)
33 Completed
Has Results 		Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
34 Completed GSK1349572 Drug Interaction Study With Efavirenz
Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae;   Healthy
Interventions: Drug: GSK1349572;   Drug: Efavirenz
35 Unknown † (Men Who Have Sex With Men) MSM Community Intervention Trial
Conditions: HIV;   Syphilis;   Herpesvirus 2, Human
Intervention: Other: behavior intervention and male circumcision
36 Completed Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza
Condition: HIV
Intervention: Biological: Foceteria® (Novartis)
37 Completed Improving Sleep and Quality of Life in Adults With HIV Disease
Condition: Insomnia
Interventions: Behavioral: Music Therapy;   Behavioral: Yoga
38 Recruiting Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Conditions: Adult Grade III Lymphomatoid Granulomatosis;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Drug: lenalidomide;   Drug: temsirolimus;   Other: laboratory biomarker analysis
39 Active, not recruiting Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting
Condition: Substance Use
Intervention:
40 Unknown † Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Condition: Kaposi's Sarcoma
Intervention: Drug: Indinavir in association with Vinblastina +/- Bleomicina
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
† Indicates status has not been verified in more than two years